Tag Archives: Chimeric Antigen Receptor T-Cell

Eureka Thera’s CAR-T treatment shrinks liver cancer in small study. What’s the big deal? Just ask Sloan-Kettering and Germany’s Boehringer.

The News: Eureka Therapeutics Inc., a closely held biotechnology company, said that liver cancer patients getting its CAR-T therapy responded to the treatment, one of the first times the immune-system… Read more »

Juno Therapeutics halts study after more patient deaths; shares crash

Juno Therapeutics Inc.’s (Seattle WA) shares plunged 23% last week after the biopharmaceutical company voluntarily placed a mid-stage clinical trial on hold after two patients suffered cerebral edema earlier in the… Read more »